Date of Award
1-1-2010
Language
English
Document Type
Dissertation
Degree Name
Doctor of Philosophy (PhD)
College/School/Department
Department of Epidemiology and Biostatistics
Program
Epidemiology
Content Description
1 online resource (xiv, 236 pages) : illustrations (some color)
Dissertation/Thesis Chair
Louise-Anne McNutt
Committee Members
Howard Stratton, Jerry O Stern, Fred Moy, Christopher Miller
Keywords
abacavir, CVD, hepatotoxicity, HIV, recurrent events, tipranavir, HIV infections, Protease inhibitors, HIV-positive persons
Subject Categories
Epidemiology | Medical Sciences
Abstract
Dose-limiting adverse events associated with anti-retroviral therapy (ART) generally include gastro-intestinal (GI) issues such as vomiting and nausea. However, serious adverse events (SAEs) do occur, the most frequent of which include liver toxicities and renal impairment as well as recent evidence of cardio-vascular disease (CVD) risk.
Recommended Citation
Mikl, Jaromir, "Safety assessment for tipranavir : a protease inhibitor treatment for HIV infected adults" (2010). Legacy Theses & Dissertations (2009 - 2024). 220.
https://scholarsarchive.library.albany.edu/legacy-etd/220